vs
dLocal Ltd（DLO）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是dLocal Ltd的1.8倍（$622.0M vs $337.9M），Royalty Pharma plc净利率更高（34.4% vs 16.5%，领先18.0%），dLocal Ltd同比增速更快（65.2% vs 4.8%）
dLocal是一家总部位于乌拉圭的金融科技企业，专注于提供跨境支付解决方案，搭建全球商户与新兴市场之间的支付链路，助力国际商户顺畅接入新兴市场本地支付网络，高效开展跨境业务。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
DLO vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.8倍
$337.9M
营收增速更快
DLO
高出60.5%
4.8%
净利率更高
RPRX
高出18.0%
16.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $337.9M | $622.0M |
| 净利润 | $55.6M | $214.2M |
| 毛利率 | 34.3% | — |
| 营业利润率 | 18.6% | 62.4% |
| 净利率 | 16.5% | 34.4% |
| 营收同比 | 65.2% | 4.8% |
| 净利润同比 | 87.3% | 2.9% |
| 每股收益（稀释后） | $0.18 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DLORPRX
| Q4 25 | $337.9M | $622.0M | ||
| Q3 25 | $282.5M | $609.3M | ||
| Q2 25 | — | $578.7M | ||
| Q1 25 | — | $568.2M | ||
| Q4 24 | $204.5M | $593.6M | ||
| Q3 24 | $185.8M | $564.7M | ||
| Q2 24 | — | $537.3M | ||
| Q1 24 | — | $568.0M |
净利润DLORPRX
| Q4 25 | $55.6M | $214.2M | ||
| Q3 25 | $141.3M | $288.2M | ||
| Q2 25 | — | $30.2M | ||
| Q1 25 | — | $238.3M | ||
| Q4 24 | $29.7M | $208.2M | ||
| Q3 24 | $90.8M | $544.0M | ||
| Q2 24 | — | $102.0M | ||
| Q1 24 | — | $4.8M |
毛利率DLORPRX
| Q4 25 | 34.3% | — | ||
| Q3 25 | 36.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 40.9% | — | ||
| Q3 24 | 42.1% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率DLORPRX
| Q4 25 | 18.6% | 62.4% | ||
| Q3 25 | 19.7% | 70.1% | ||
| Q2 25 | — | 36.3% | ||
| Q1 25 | — | 94.0% | ||
| Q4 24 | 20.7% | 60.9% | ||
| Q3 24 | 22.1% | — | ||
| Q2 24 | — | 50.2% | ||
| Q1 24 | — | -13.0% |
净利率DLORPRX
| Q4 25 | 16.5% | 34.4% | ||
| Q3 25 | 50.0% | 47.3% | ||
| Q2 25 | — | 5.2% | ||
| Q1 25 | — | 41.9% | ||
| Q4 24 | 14.5% | 35.1% | ||
| Q3 24 | 48.9% | 96.3% | ||
| Q2 24 | — | 19.0% | ||
| Q1 24 | — | 0.8% |
每股收益（稀释后）DLORPRX
| Q4 25 | $0.18 | $0.49 | ||
| Q3 25 | $0.17 | $0.67 | ||
| Q2 25 | — | $0.07 | ||
| Q1 25 | — | $0.55 | ||
| Q4 24 | $0.09 | $0.46 | ||
| Q3 24 | $0.09 | $1.21 | ||
| Q2 24 | — | $0.23 | ||
| Q1 24 | — | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $719.9M | $618.7M |
| 总债务越低越好 | $86.7M | $9.0B |
| 股东权益账面价值 | $569.4M | $9.7B |
| 总资产 | $1.5B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.15× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资DLORPRX
| Q4 25 | $719.9M | $618.7M | ||
| Q3 25 | $604.5M | $938.9M | ||
| Q2 25 | — | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | $425.2M | $929.0M | ||
| Q3 24 | $560.5M | $950.1M | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | — | $843.0M |
总债务DLORPRX
| Q4 25 | $86.7M | $9.0B | ||
| Q3 25 | $63.1M | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $39.8M | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益DLORPRX
| Q4 25 | $569.4M | $9.7B | ||
| Q3 25 | $504.7M | $9.6B | ||
| Q2 25 | — | $9.5B | ||
| Q1 25 | — | $9.8B | ||
| Q4 24 | $489.0M | $10.3B | ||
| Q3 24 | $457.0M | $10.3B | ||
| Q2 24 | — | $9.8B | ||
| Q1 24 | — | $9.9B |
总资产DLORPRX
| Q4 25 | $1.5B | $19.6B | ||
| Q3 25 | $1.4B | $19.3B | ||
| Q2 25 | — | $18.3B | ||
| Q1 25 | — | $17.6B | ||
| Q4 24 | $1.2B | $18.2B | ||
| Q3 24 | — | $18.0B | ||
| Q2 24 | — | $17.7B | ||
| Q1 24 | — | $16.1B |
负债/权益比DLORPRX
| Q4 25 | 0.15× | 0.92× | ||
| Q3 25 | 0.12× | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 0.08× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $100.4M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $99.8M | — |
| 自由现金流率自由现金流/营收 | 29.5% | — |
| 资本支出强度资本支出/营收 | 0.2% | — |
| 现金转化率经营现金流/净利润 | 1.80× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $378.7M | — |
8季度趋势，按日历期对齐
经营现金流DLORPRX
| Q4 25 | $100.4M | $827.1M | ||
| Q3 25 | $315.0M | $702.6M | ||
| Q2 25 | — | $364.0M | ||
| Q1 25 | — | $596.1M | ||
| Q4 24 | $-141.1M | $742.5M | ||
| Q3 24 | $108.3M | $703.6M | ||
| Q2 24 | — | $658.2M | ||
| Q1 24 | — | $664.6M |
自由现金流DLORPRX
| Q4 25 | $99.8M | — | ||
| Q3 25 | $313.4M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-141.6M | — | ||
| Q3 24 | $107.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率DLORPRX
| Q4 25 | 29.5% | — | ||
| Q3 25 | 110.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -69.2% | — | ||
| Q3 24 | 57.6% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度DLORPRX
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率DLORPRX
| Q4 25 | 1.80× | 3.86× | ||
| Q3 25 | 2.23× | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | -4.75× | 3.57× | ||
| Q3 24 | 1.19× | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DLO
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
